Contraceptive Method Use and Chlamydia Positivity Among California Family Planning Clients: The Case for New...

Area of Science:

• Reproductive Health
• Infectious Disease Epidemiology
• Public Health

Background:

• Adolescent girls and young women face high rates of sexually transmitted infections (STIs).
• Current contraceptive methods offer limited protection against STIs.
• Few studies have analyzed chlamydial infection rates based on contraceptive method use.

Purpose of the Study:

• To examine the prevalence of chlamydial infection among female family planning clients.
• To compare chlamydia positivity rates across different contraceptive method tiers.
• To assess the association between condom provision and chlamydia positivity.

Main Methods:

• Cross-sectional analysis of claims data from a California family planning program (July 2012-June 2013).
• Linked contraceptive method data with chlamydia laboratory test results for 74,636 female clients aged 15-29.
• Classified contraceptive methods into tiers: tier 1 (high-efficacy long-acting/permanent), tier 2 (shorter-acting hormonal), and tier 3 (other methods).
• Used log-binomial models to estimate adjusted prevalence ratios.

Main Results:

• Overall chlamydia positivity was 5.1% among the study population.
• Chlamydia positivity was highest in tier 2 users (5.3%) compared to tier 1 (4.5%) and tier 3 (4.9%), though adjusted analyses showed no significant differences by tier.
• Clients who received condoms had significantly higher chlamydia positivity (6.3% vs. 4.3%) and were 1.32 times more likely to test positive.

Conclusions:

• High chlamydia positivity exists among young women utilizing family planning services, irrespective of their primary contraceptive method.
• The findings highlight an unmet need for integrated prevention strategies.
• Development of Multipurpose Prevention Technologies offering dual protection against pregnancy and STIs is recommended.